TMDX
TransMedics Group Inc.
Company Overview
| Mkt Cap | $4.17B | Price | $131.54 |
| Volume | 1.35M | Change | -3.13% |
| P/E Ratio | 117.6 | Open | $135.67 |
| Revenue | $441.5M | Prev Close | $135.79 |
| Net Income | $35.5M | 52W Range | $55.00 - $145.50 |
| Div Yield | N/A | Target | $141.64 |
| Overall | 60 | Value | 20 |
| Quality | -- | Technical | 100 |
No chart data available
Stock Overview
Updated DailyTransMedics Group Inc. (TMDX) is a leading Healthcare company in the Medical Devices industry, currently trading at $131.54 with a market capitalization of $4.17 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TMDX with a volume of 1.35 million shares. The stock opened down 0.09% from yesterday's close of $135.79. Current analyst estimates project earnings of $2.34 per share for this year, with next year targeting $2.67.
TMDX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including PAVM, PECN, PEYE, PACB.
Key investment considerations for TMDX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 7.7%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:40 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMDX | $131.54 | -3.1% | 1.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |